Oaktree Specialty Lending Corp - 10-K Filing
Oaktree Specialty Lending Corp reports extensive investment portfolio composition across diverse sectors including Pharmaceuticals, Biotechnology, and Application Software for fiscal year ending September 30, 2026.
Coverage
- Oaktree Specialty Lending Reports Q4 Adjusted Net Investment Income in Line With Estimates
- Oaktree Specialty Lending Announces $0.30 Quarterly and $0.02 Supplemental Dividend
- Oaktree Specialty Lending Reports Q4 Non-GAAP EPS of $0.34 and Declares Distributions
- Oaktree Specialty Lending Corp - 10-K Filing
- Oaktree Specialty Lending Corp - 8-K Filing